Market Tracker

04/28 5:16pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.33
Delayed Data
As of Apr 28
 -0.0321 / -8.86%
Today’s Change
0.30
Today|||52-Week Range
4.00
-49.16%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close0.36
Today’s open0.36
Day’s range0.30 - 0.36
Volume6,202,344
Average volume (3 months)2,451,471
Market cap$26.5M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book3.93

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.05+2.16%
RPRXRepros Therapeutics ...+0.02+1.94%
HTBXHeat Biologics Inc+0.02+1.95%
NEOTNeothetics Inc-0.11-5.39%
Data as of 3:59pm ET, 04/28/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts